Norinchukin Bank The raised its position in Cerner Co. (NASDAQ:CERN) by 7.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 25,249 shares of the company’s stock after acquiring an additional 1,804 shares during the period. Norinchukin Bank The’s holdings in Cerner were worth $1,702,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. FDx Advisors Inc. increased its holdings in shares of Cerner by 15.4% in the 4th quarter. FDx Advisors Inc. now owns 22,500 shares of the company’s stock valued at $1,516,000 after purchasing an additional 3,005 shares in the last quarter. ARP Americas LP increased its holdings in shares of Cerner by 128.9% in the 4th quarter. ARP Americas LP now owns 6,680 shares of the company’s stock valued at $450,000 after purchasing an additional 3,762 shares in the last quarter. Synovus Financial Corp increased its holdings in shares of Cerner by 2.8% in the 4th quarter. Synovus Financial Corp now owns 46,306 shares of the company’s stock valued at $3,114,000 after purchasing an additional 1,241 shares in the last quarter. American International Group Inc. increased its holdings in shares of Cerner by 7.0% in the 4th quarter. American International Group Inc. now owns 149,668 shares of the company’s stock valued at $10,086,000 after purchasing an additional 9,758 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Cerner by 230.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,671 shares of the company’s stock valued at $450,000 after purchasing an additional 4,654 shares in the last quarter. Institutional investors own 81.63% of the company’s stock.
Shares of Cerner Co. (CERN) opened at $64.53 on Friday. Cerner Co. has a 12 month low of $54.01 and a 12 month high of $73.86. The stock has a market cap of $20,923.70, a PE ratio of 25.11, a price-to-earnings-growth ratio of 1.88 and a beta of 0.90. The company has a current ratio of 3.01, a quick ratio of 2.99 and a debt-to-equity ratio of 0.11.
Cerner (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). Cerner had a return on equity of 16.82% and a net margin of 16.86%. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the business earned $0.61 earnings per share. Cerner’s revenue for the quarter was up 4.5% on a year-over-year basis. sell-side analysts predict that Cerner Co. will post 2.42 earnings per share for the current fiscal year.
In other Cerner news, President Zane M. Burke sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $70.00, for a total transaction of $3,500,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Jeffrey A. Townsend sold 230,000 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $61.94, for a total transaction of $14,246,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 348,100 shares of company stock worth $22,519,016 over the last ninety days. 13.11% of the stock is owned by corporate insiders.
CERN has been the subject of a number of research analyst reports. Zacks Investment Research upgraded shares of Cerner from a “sell” rating to a “hold” rating in a report on Tuesday, December 26th. Stifel Nicolaus restated a “hold” rating on shares of Cerner in a report on Wednesday, November 22nd. BidaskClub downgraded shares of Cerner from a “buy” rating to a “hold” rating in a report on Friday, December 22nd. JPMorgan Chase & Co. downgraded shares of Cerner from an “overweight” rating to a “neutral” rating in a report on Friday, October 27th. Finally, SunTrust Banks restated a “buy” rating and set a $75.00 target price on shares of Cerner in a report on Monday, October 30th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have given a buy rating to the company’s stock. Cerner currently has a consensus rating of “Hold” and a consensus price target of $67.05.
COPYRIGHT VIOLATION WARNING: “Cerner Co. (CERN) Stake Increased by Norinchukin Bank The” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/24/cerner-co-cern-stake-increased-by-norinchukin-bank-the.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.